STAT3

a multifaceted oncoprotein

Aleks C. Guanizo, Chamira Dilanka Fernando, Daniel J. Garama, Daniel J. Gough

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Signal transducer and activator of transcription (STAT) 3 is a key signalling protein engaged by a multitude of growth factors and cytokines to elicit diverse biological outcomes including cellular growth, differentiation, and survival. The complete loss of STAT3 is not compatible with life and even partial loss of function mutations lead to debilitating pathologies like hyper IgE syndrome. Conversely, augmented STAT3 activity has been reported in as many as 50% of all human tumours. The dogma of STAT3 activity posits that it is a tyrosine phosphorylated transcription factor which modulates the expression of hundreds of genes. However, the regulation and biological consequences of STAT3 activation are far more complex. In addition to tyrosine phosphorylation, STAT3 is decorated with a plethora of post-translational modifications which regulate STAT3’s nuclear function in addition to its non-genomic activities. In addition to these emerging complexities in the biochemical regulation of STAT3 activity, recent studies reveal that STAT3 is either oncogenic or a tumour suppressor. This review will explore these complexities.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalGrowth Factors
Volume36
Issue number1-2
DOIs
Publication statusPublished - 4 Mar 2018

Keywords

  • cancer
  • mitochondria
  • post-translational modifications
  • STAT3

Cite this

Guanizo, Aleks C. ; Fernando, Chamira Dilanka ; Garama, Daniel J. ; Gough, Daniel J. / STAT3 : a multifaceted oncoprotein. In: Growth Factors. 2018 ; Vol. 36, No. 1-2. pp. 1-14.
@article{af6c0dcf7d714b55b1e489b0692f93f5,
title = "STAT3: a multifaceted oncoprotein",
abstract = "Signal transducer and activator of transcription (STAT) 3 is a key signalling protein engaged by a multitude of growth factors and cytokines to elicit diverse biological outcomes including cellular growth, differentiation, and survival. The complete loss of STAT3 is not compatible with life and even partial loss of function mutations lead to debilitating pathologies like hyper IgE syndrome. Conversely, augmented STAT3 activity has been reported in as many as 50{\%} of all human tumours. The dogma of STAT3 activity posits that it is a tyrosine phosphorylated transcription factor which modulates the expression of hundreds of genes. However, the regulation and biological consequences of STAT3 activation are far more complex. In addition to tyrosine phosphorylation, STAT3 is decorated with a plethora of post-translational modifications which regulate STAT3’s nuclear function in addition to its non-genomic activities. In addition to these emerging complexities in the biochemical regulation of STAT3 activity, recent studies reveal that STAT3 is either oncogenic or a tumour suppressor. This review will explore these complexities.",
keywords = "cancer, mitochondria, post-translational modifications, STAT3",
author = "Guanizo, {Aleks C.} and Fernando, {Chamira Dilanka} and Garama, {Daniel J.} and Gough, {Daniel J.}",
year = "2018",
month = "3",
day = "4",
doi = "10.1080/08977194.2018.1473393",
language = "English",
volume = "36",
pages = "1--14",
journal = "Growth Factors",
issn = "0897-7194",
publisher = "Taylor & Francis",
number = "1-2",

}

STAT3 : a multifaceted oncoprotein. / Guanizo, Aleks C.; Fernando, Chamira Dilanka; Garama, Daniel J.; Gough, Daniel J.

In: Growth Factors, Vol. 36, No. 1-2, 04.03.2018, p. 1-14.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - STAT3

T2 - a multifaceted oncoprotein

AU - Guanizo, Aleks C.

AU - Fernando, Chamira Dilanka

AU - Garama, Daniel J.

AU - Gough, Daniel J.

PY - 2018/3/4

Y1 - 2018/3/4

N2 - Signal transducer and activator of transcription (STAT) 3 is a key signalling protein engaged by a multitude of growth factors and cytokines to elicit diverse biological outcomes including cellular growth, differentiation, and survival. The complete loss of STAT3 is not compatible with life and even partial loss of function mutations lead to debilitating pathologies like hyper IgE syndrome. Conversely, augmented STAT3 activity has been reported in as many as 50% of all human tumours. The dogma of STAT3 activity posits that it is a tyrosine phosphorylated transcription factor which modulates the expression of hundreds of genes. However, the regulation and biological consequences of STAT3 activation are far more complex. In addition to tyrosine phosphorylation, STAT3 is decorated with a plethora of post-translational modifications which regulate STAT3’s nuclear function in addition to its non-genomic activities. In addition to these emerging complexities in the biochemical regulation of STAT3 activity, recent studies reveal that STAT3 is either oncogenic or a tumour suppressor. This review will explore these complexities.

AB - Signal transducer and activator of transcription (STAT) 3 is a key signalling protein engaged by a multitude of growth factors and cytokines to elicit diverse biological outcomes including cellular growth, differentiation, and survival. The complete loss of STAT3 is not compatible with life and even partial loss of function mutations lead to debilitating pathologies like hyper IgE syndrome. Conversely, augmented STAT3 activity has been reported in as many as 50% of all human tumours. The dogma of STAT3 activity posits that it is a tyrosine phosphorylated transcription factor which modulates the expression of hundreds of genes. However, the regulation and biological consequences of STAT3 activation are far more complex. In addition to tyrosine phosphorylation, STAT3 is decorated with a plethora of post-translational modifications which regulate STAT3’s nuclear function in addition to its non-genomic activities. In addition to these emerging complexities in the biochemical regulation of STAT3 activity, recent studies reveal that STAT3 is either oncogenic or a tumour suppressor. This review will explore these complexities.

KW - cancer

KW - mitochondria

KW - post-translational modifications

KW - STAT3

UR - http://www.scopus.com/inward/record.url?scp=85048062492&partnerID=8YFLogxK

U2 - 10.1080/08977194.2018.1473393

DO - 10.1080/08977194.2018.1473393

M3 - Review Article

VL - 36

SP - 1

EP - 14

JO - Growth Factors

JF - Growth Factors

SN - 0897-7194

IS - 1-2

ER -